APOE and Alzheimer disease: Despite these limitations, our study has several strengths, including the relatively large sample with both high-quality microbiome and PET imaging data, the use of robust statistical tools with multiple comparison correction, and replication of known microbiome–AD associations, which adds credibility to our novel findings about APOE interactions.